Evaluation of the relationship between muscle mass and serum myostatin levels in chronic hemodialysis patients
The loss of muscle mass and cachexia is commonly seen in hemodialysis (HD) patients and contribute to morbidity and mortality. The exact mechanism of this fact is multifactorial and still unclear. Myostatin, a transforming growth factor-ß family ligand, is released from the skeletal and heart muscle...
Main Authors: | Derya Koyun, Gokhan Nergizoglu, Kemal Metin Kir |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2018;volume=29;issue=4;spage=809;epage=815;aulast=Koyun |
Similar Items
-
Significance of serum Myostatin in hemodialysis patients
by: Pasquale Esposito, et al.
Published: (2019-12-01) -
ESTRADIOL IN FEMALES MAY NEGATE SKELETAL MUSCLE MYOSTATIN MRNA EXPRESSION AND SERUM MYOSTATIN PROPEPTIDE LEVELS AFTER ECCENTRIC MUSCLE CONTRACTIONS
by: Darryn S. Willoughby, et al.
Published: (2006-12-01) -
Serum myokine (myostatin and IGF-1) measurement as predictors in hemodialysis patients
by: Homare Shimohata, et al.
Published: (2019-05-01) -
Muscle and serum myostatin expression in type 1 diabetes
by: Athan G. Dial, et al.
Published: (2020-07-01) -
The Regulation of Myostatin and Its Relationship with Muscle Atrophy
by: Der-Sheng Han, et al.
Published: (2011)